Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Extension Study of AMG 531 in Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
This study is enrolling participants by invitation only.
Study NCT00116688   Information provided by Amgen
First Received: June 30, 2005   Last Updated: October 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thrombocytopenia
Idiopathic Thrombocytopenic Purpura
Additional conditions recognized in this trial
Purpura
Purpura, Thrombocytopenic
Purpura, Thrombocytopenic, Idiopathic
More general conditions related to this trial
Autoimmune Diseases
Blood Coagulation Disorders
Blood Platelet Disorders
Hematologic Diseases
Hemorrhagic Disorders
Immune System Diseases
Signs and Symptoms
Skin Manifestations
Interventions listed in this trial
AMG 531
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services